Cargando…
Breakthrough medicines during the COVID-19 pandemic era
Autores principales: | Ghali, Eswara Naga Hanuma Kumar, Dhevan, Vijian, K Narmala, Shravan, Jaggi, Meena, C Chauhan, Subhash, M Yallapu, Murali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842712/ https://www.ncbi.nlm.nih.gov/pubmed/37379446 http://dx.doi.org/10.4155/fdd-2022-0002 |
Ejemplares similares
-
Therapeutics to tackle Omicron outbreak
por: Chavda, Vivek P, et al.
Publicado: (2022) -
Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction
por: Sikander, Mohammed, et al.
Publicado: (2020) -
miRNA-205: a future therapeutic molecule for liver diseases
por: Cabrera, Marco, et al.
Publicado: (2023) -
Withania somnifera as a potential future drug molecule for COVID-19
por: Kashyap, Vivek K, et al.
Publicado: (2020) -
Scope of nanotechnology in ovarian cancer therapeutics
por: Yallapu, Murali M, et al.
Publicado: (2010)